Reuters logo
BRIEF-Carmot Enters A Multi-Year Drug Discovery Collaboration With Amgen
December 6, 2017 / 12:18 PM / 6 days ago

BRIEF-Carmot Enters A Multi-Year Drug Discovery Collaboration With Amgen

Dec 6 (Reuters) - Amgen Inc:

* CARMOT ENTERS A MULTI-YEAR DRUG DISCOVERY COLLABORATION WITH AMGEN

* CARMOT THERAPEUTICS SAYS HAS ENTERED INTO A MULTI-YEAR DRUG DISCOVERY COLLABORATION AND LICENSING AGREEMENT WITH AMGEN

* CARMOT THERAPEUTICS SAYS AS PART OF AGREEMENT, CARMOT AND AMGEN WILL WORK TOGETHER TO SELECT THERAPEUTIC TARGETS AND IDENTIFY DRUG CANDIDATES

* CARMOT THERAPEUTICS SAYS UNDER AGREEMENT, AMGEN CAN SELECT MULTIPLE TARGETS TO PURSUE AND CARMOT WILL RECEIVE AN UPFRONT PAYMENT AND RESEARCH SUPPORT

* CARMOT THERAPEUTICS SAYS IN ADDITION, CARMOT IS ELIGIBLE TO RECEIVE ROYALTIES ON NET SALES OF PRODUCTS RESULTING FROM COLLABORATION Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below